Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Star Therapeutics
Star Therapeutics
Biotech
Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
The 2026 IPO streak continues as Electra Therapeutics has filed to go public to support its immunology and cancer pipeline.
Will Maddox
Aug 31, 2026 11:27am
Incyte inks $2B deal to add Star biz to late-phase constellation
Jun 8, 2026 9:07am
ASH: Star antibody sparkles in preview of possible ph. 3 success
Dec 7, 2025 9:40am
Starry-eyed Star blazes forward with $125M funding boost
Sep 30, 2025 6:30am
Electra picks commercially-minded Kathy Dong as next CEO
Dec 11, 2023 7:00am
Investors shower Star Therapeutics with $90M series C
Sep 5, 2023 7:00am